SK19242000A3 - Izolovaná molekula nukleovej kyseliny kódujúca polypeptid zúčastňujúci sa biosyntézy epotilónov, chimérický gén, rekombinantný vektor a rekombinantná hostiteľská bunka obsahujúce túto nukleovú kyselinu, spôsob prípravy epotilónu a izolovaný polypeptid obsahujúci epotilónsyntázovú doménu - Google Patents

Izolovaná molekula nukleovej kyseliny kódujúca polypeptid zúčastňujúci sa biosyntézy epotilónov, chimérický gén, rekombinantný vektor a rekombinantná hostiteľská bunka obsahujúce túto nukleovú kyselinu, spôsob prípravy epotilónu a izolovaný polypeptid obsahujúci epotilónsyntázovú doménu Download PDF

Info

Publication number
SK19242000A3
SK19242000A3 SK1924-2000A SK19242000A SK19242000A3 SK 19242000 A3 SK19242000 A3 SK 19242000A3 SK 19242000 A SK19242000 A SK 19242000A SK 19242000 A3 SK19242000 A3 SK 19242000A3
Authority
SK
Slovakia
Prior art keywords
seq
nucleotides
amino acids
nucleic acid
amino
Prior art date
Application number
SK1924-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Thomas Schupp
James Madison Ligon
Istvan Molnar
Ross Zirkle
J�Rn G�Rlach
Devon Cyr
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SK19242000A3 publication Critical patent/SK19242000A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
SK1924-2000A 1998-06-18 1999-06-16 Izolovaná molekula nukleovej kyseliny kódujúca polypeptid zúčastňujúci sa biosyntézy epotilónov, chimérický gén, rekombinantný vektor a rekombinantná hostiteľská bunka obsahujúce túto nukleovú kyselinu, spôsob prípravy epotilónu a izolovaný polypeptid obsahujúci epotilónsyntázovú doménu SK19242000A3 (sk)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9950498A 1998-06-18 1998-06-18
US10163198P 1998-09-24 1998-09-24
US11890699P 1999-02-05 1999-02-05
PCT/EP1999/004171 WO1999066028A2 (en) 1998-06-18 1999-06-16 Genes for the biosynthesis of epothilones

Publications (1)

Publication Number Publication Date
SK19242000A3 true SK19242000A3 (sk) 2001-07-10

Family

ID=27378840

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1924-2000A SK19242000A3 (sk) 1998-06-18 1999-06-16 Izolovaná molekula nukleovej kyseliny kódujúca polypeptid zúčastňujúci sa biosyntézy epotilónov, chimérický gén, rekombinantný vektor a rekombinantná hostiteľská bunka obsahujúce túto nukleovú kyselinu, spôsob prípravy epotilónu a izolovaný polypeptid obsahujúci epotilónsyntázovú doménu

Country Status (16)

Country Link
EP (1) EP1088078A2 (ja)
JP (3) JP2002518004A (ja)
KR (1) KR100511233B1 (ja)
CN (1) CN100374565C (ja)
AU (1) AU753567B2 (ja)
BR (1) BR9911349A (ja)
CA (1) CA2329774A1 (ja)
HU (1) HUP0102186A3 (ja)
ID (1) ID29128A (ja)
IL (3) IL139735A0 (ja)
NO (2) NO20006195L (ja)
NZ (1) NZ508326A (ja)
PL (1) PL200157B1 (ja)
SK (1) SK19242000A3 (ja)
TR (1) TR200003759T2 (ja)
WO (1) WO1999066028A2 (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001124A1 (en) 1996-12-03 1999-01-14 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
FR2775187B1 (fr) 1998-02-25 2003-02-21 Novartis Ag Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo
DE19846493A1 (de) * 1998-10-09 2000-04-13 Biotechnolog Forschung Gmbh DNA-Sequenzen für die enzymatische Synthese von Polyketid- oder Heteropolyketidverbindungen
JP4662635B2 (ja) 1998-11-20 2011-03-30 コーサン バイオサイエンシーズ， インコーポレイテッド エポチロンおよびエポチロン誘導体を生成するための組換え方法および材料
US6410301B1 (en) 1998-11-20 2002-06-25 Kosan Biosciences, Inc. Myxococcus host cells for the production of epothilones
WO2001053533A2 (en) * 2000-01-21 2001-07-26 Kosan Biosciences, Inc. Method for cloning polyketide synthase genes
US6998256B2 (en) 2000-04-28 2006-02-14 Kosan Biosciences, Inc. Methods of obtaining epothilone D using crystallization and /or by the culture of cells in the presence of methyl oleate
ATE309369T1 (de) * 2000-04-28 2005-11-15 Kosan Biosciences Inc Heterologe herstellung von polyketiden
IL155306A0 (en) 2000-10-13 2003-11-23 Univ Mississippi Methods for producing epothilone derivatives and analogs and epothilone derivatives and analogs produced thereby
US7257562B2 (en) 2000-10-13 2007-08-14 Thallion Pharmaceuticals Inc. High throughput method for discovery of gene clusters
SI1483251T1 (sl) 2002-03-12 2010-03-31 Bristol Myers Squibb Co C cian epotilonski derivati
US7767399B2 (en) * 2005-01-31 2010-08-03 Merck & Co., Inc. Purification process for plasmid DNA
DK2668284T3 (en) 2011-01-28 2014-12-15 Amyris Inc Screening of colony micro encapsulated in gel
MX2013013065A (es) 2011-05-13 2013-12-02 Amyris Inc Metodos y composiciones para detectar la produccion microbiana de compuestos inmiscibles em agua.
BR112015002724B1 (pt) 2012-08-07 2022-02-01 Total Marketing Services Método para produzir um composto não catabólico heterólogo, e, composição de fermentação
BR112015023089A2 (pt) 2013-03-15 2017-11-21 Amyris Inc célula hospedeira, método para produzir um isoprenoide, e método para aumentar a produção de acetil-coa ou um composto derivado de acetil-coa
CN105934517A (zh) 2013-08-07 2016-09-07 阿迈瑞斯公司 用于稳定生产乙酰辅酶a衍生化合物的方法
AU2016284689B9 (en) 2015-06-25 2022-01-20 Amyris, Inc. Maltose dependent degrons, maltose-responsive promoters, stabilization constructs, and their use in production of non-catabolic compounds
CN106916834B (zh) * 2015-12-24 2022-08-05 武汉合生科技有限公司 化合物的生物合成基因簇及其应用
CN111138444B (zh) * 2020-01-08 2022-05-03 山东大学 一组埃博霉素b葡萄糖苷类化合物及其酶法制备与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU753546B2 (en) * 1996-11-18 2002-10-24 Helmholtz-Zentrum Fuer Infektionsforschung Gmbh Epothilone C, D, E and F, production process, and their use as cytostatic as well as phytosanitary agents

Also Published As

Publication number Publication date
IL139735A0 (en) 2002-02-10
HUP0102186A2 (hu) 2001-10-28
KR100511233B1 (ko) 2005-08-31
NZ508326A (en) 2003-10-31
NO20006195L (no) 2001-02-16
IL190391A0 (en) 2008-11-03
WO1999066028A3 (en) 2000-06-29
AU4611699A (en) 2000-01-05
CN100374565C (zh) 2008-03-12
WO1999066028A2 (en) 1999-12-23
CN1305530A (zh) 2001-07-25
TR200003759T2 (tr) 2001-06-21
PL345579A1 (en) 2001-12-17
NO20091055L (no) 2001-02-16
BR9911349A (pt) 2001-03-13
HUP0102186A3 (en) 2005-10-28
JP2008092958A (ja) 2008-04-24
JP2002518004A (ja) 2002-06-25
ID29128A (id) 2001-08-02
IL139735A (en) 2009-06-15
KR20010052962A (ko) 2001-06-25
CA2329774A1 (en) 1999-12-23
AU753567B2 (en) 2002-10-24
PL200157B1 (pl) 2008-12-31
JP2006061166A (ja) 2006-03-09
NO20006195D0 (no) 2000-12-06
EP1088078A2 (en) 2001-04-04

Similar Documents

Publication Publication Date Title
US6355458B1 (en) Genes for the biosynthesis of epothilones
KR100511233B1 (ko) 에포틸론 생합성 유전자
AU753546B2 (en) Epothilone C, D, E and F, production process, and their use as cytostatic as well as phytosanitary agents
US7172884B2 (en) Methods for the preparation, isolation and purification of epothilone B, and x-ray crystal structures of epothilone B
IL138241A (en) Biosynthetic genes for the production of the insecticide Spinosine
KR20100049580A (ko) 티오펩티드 전구체 단백질, 그를 코딩하는 유전자 및 그의 용도
CN100374566C (zh) 用于epothilone生物合成的基因
CZ20004693A3 (cs) Izolovaná nukleová kyselina kódující polypeptid účastnící se biosyntézy epothilonu, chimérický gen, vektor a hostitelské buňky obsahující tuto nukleovou kyselinu
TWI770070B (zh) 經修飾之抗真菌鏈黴菌(streptomyces fungicidicus)分離株及其用途
MXPA00012342A (en) Genes for the biosynthesis of epothilones
KR20050050146A (ko) 글리코펩티드 항생제 ａ４０９２６의 생합성을 위한 유전자및 단백질
RU2265054C2 (ru) Рекомбинантная клетка-хозяин (варианты) и клон вас
CA2381427A1 (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
RU2234532C2 (ru) Нуклеиновая кислота (варианты), ее использование для экспрессии эпотилонов, полипептид (варианты), клон бактерий е.coli
CN100359014C (zh) 一类新型埃坡霉素化合物及其制备方法和用途
CN1031948C (zh) 抗生素ge2270的制备方法
RU2773311C2 (ru) Модифицированные изоляты streptomyces fungicidicus и их применение
CZ279196B6 (cs) Protinádorové antibiotikum kedarcidin

Legal Events

Date Code Title Description
FC9A Refused patent application